Connor, Clark & Lunn Investment Management (CC&L)
AMAG

Connor, Clark & Lunn Investment Management (CC&L)’s AMAG Pharmaceuticals AMAG Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-119,399
Closed -$1.12M – 1091
2020
Q3 		$1.12M Sell
119,399
-239,278
-67% -$2.27M 0.01% 599
2020
Q2 		$2.74M Sell
358,677
-49,905
-12% -$382K 0.02% 396
2020
Q1 		$2.52M Sell
408,582
-271,608
-40% -$2.39M 0.02% 370
2019
Q4 		$8.28M Sell
680,190
-113,875
-14% -$1.24M 0.06% 202
2019
Q3 		$9.17M Buy
794,065
+3,641
+0.5% +$38.3K 0.06% 183
2019
Q2 		$7.9M Buy
790,424
+87,336
+12% +$942K 0.05% 215
2019
Q1 		$9.06M Buy
703,088
+5,436
+0.8% +$81K 0.06% 204
2018
Q4 		$10.6M Buy
697,652
+56,122
+9% +$1.07M 0.07% 182
2018
Q3 		$12.8M Buy
641,530
+10,885
+2% +$248K 0.07% 187
2018
Q2 		$12.3M Sell
630,645
-38,275
-6% -$847K 0.07% 196
2018
Q1 		$13.5M Sell
668,920
-69,925
-9% -$1.18M 0.08% 173
2017
Q4 		$9.79M Buy
738,845
+174,574
+31% +$2.63M 0.06% 206
2017
Q3 		$10.4M Buy
564,271
+203,800
+57% +$3.8M 0.06% 208
2017
Q2 		$6.63M Buy
360,471
+172,851
+92% +$3.43M 0.04% 237
2017
Q1 		$4.23M Buy
187,620
+95,650
+104% +$2.29M 0.03% 276
2016
Q4 		$3.2M Buy
91,970
+7,325
+9% +$219K 0.02% 304
2016
Q3 		$2.08M Sell
84,645
-51,380
-38% -$1.28M 0.01% 358
2016
Q2 		$3.25M Sell
136,025
-42,600
-24% -$977K 0.02% 292
2016
Q1 		$4.18M Buy
178,625
+2,525
+1% +$59.9K 0.03% 244
2015
Q4 		$5.32M Buy
176,100
+21,500
+14% +$695K 0.04% 201
2015
Q3 		$6.14M Buy
154,600
+17,075
+12% +$1.06M 0.05% 178
2015
Q2 		$9.5M Sell
137,525
-24,775
-15% -$1.56M 0.09% 112
2015
Q1 		$8.87M Buy
162,300
+49,100
+43% +$2.34M 0.07% 122
2014
Q4 		$4.83M Buy
+113,200
New +$4.09M 0.04% 161

Connor, Clark & Lunn Investment Management (CC&L)'s AMAG Position: Q4 2020 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 119,399 shares — an estimated $1.12M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AMAG in Q4 2014 and held it in 24 quarters. The position peaked at $13.5M in Q1 2018. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 119,399 AMAG Pharmaceuticals shares in Q4 2020, an estimated $1.12M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 24 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s AMAG Pharmaceuticals position peaked at $13.5M in Q1 2018.
  • 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2020, filed 16 Feb 2021.